心臓POC検査機器市場：製品タイプ、用途、エンドユーザー別-2025-2030年の世界予測

心臓POC検査機器市場は、2023年に13億6,000万米ドルと評価され、2024年には15億2,000万米ドル、CAGR 12.36%で成長し、2030年には30億8,000万米ドルに達すると予測されています。

心臓のポイントオブケア（POC）検査市場は、技術の進歩、臨床ニーズの変化、より迅速で信頼性の高い診断への需要の合流によって急速に発展してきました。このダイナミックな分野は、ヘルスケアプロバイダーによる心臓疾患のスクリーニング、診断、管理方法を再定義しつつあります。バイオマーカー検出とポータブル機器工学における最近の動向は、ベッドサイドや遠隔地で心臓の健康状態を迅速に評価する非常に効率的な方法をもたらしました。

診断技術における革新と精度は、心臓の緊急事態にタイムリーに介入するために不可欠となっています。患者ケアの動向が分散化と患者中心モデルにシフトするにつれて、心臓POC検査機器の関連性と用途は拡大しています。高度なバイオマーカー検査と洗練された機器工学の統合が、精度の向上と運用の柔軟性に対する緊急のニーズに応えるにつれて、これらの機器の状況は継続的に変革的な成長を遂げようとしています。

この包括的な概要では、心臓POC検査市場をさまざまな角度から調査し、市場シフトの変革、詳細なセグメンテーションの洞察、地域別のビジネスチャンス、主要企業、実行可能な戦略的提言、これらの動向を活用しようとする意思決定者への説得力のある呼びかけなどを明らかにします。

心臓POC検査を再定義する変革的シフト

近年、心臓POC検査の領域は、技術的な飛躍的進歩と臨床需要の変化の両方によって推進される変革的な変化を遂げています。技術革新の急増は、心臓疾患の早期発見と継続的モニタリングを強化する新規診断法の開発につながりました。この変革は、精度、スピード、および患者に近い検査ソリューションを提供する能力の向上によって顕著に現れ、最終的に患者の転帰改善に寄与しています。

この変化の主な推進力には、デジタルヘルスツールとAI支援診断の統合が含まれ、これらのツールは結果の解釈を合理化し、より個別化された治療経路を可能にします。小型化とセンサー技術の進歩により、機器はよりポータブルで使いやすくなり、多様なヘルスケア環境でその役割を高めています。さらに、自動化システムの統合とともに、心臓バイオマーカー検査の納期短縮に重点を置くことは、重要な時期における診断の遅れを軽減するのに役立っています。

こうしたダイナミックな変化は、迅速で正確な診断が望ましいだけでなく不可欠な市場環境を形成しています。ヘルスケアシステムが世界的に効率化と患者ケアの向上を目指し続ける中、機器の機能と診断精度の継続的な向上は間違いなく将来の標準を設定し、市場成長の新たな道を切り開くと思われます。

市場セグメンテーション分析による主な洞察

市場セグメンテーションの複雑な階層を理解することは、心臓POC検査市場内の機会と課題を特定するための強固な枠組みを提供します。製品に基づく分析により、市場は心臓バイオマーカー検査、消耗品＆アクセサリー、デバイスなどのセグメントに区別されます。心臓バイオマーカー検査セグメントは、B型ナトリウム利尿ペプチド、クレアチンキナーゼ-MB（CK-MB）フラクション、Dダイマー検査、ミオグロビン検査、トロポニン検査などの特定の検査にさらに細分化されています。一方、デバイス分野では、分析装置とイメージング＆モニタリングデバイスのレンズを通して調査し、分析性能とリアルタイムモニタリング機能の両方の重要性を強調しています。

デバイスの種類別に市場を見ると、ベンチトップ型POCデバイス、ハンドヘルド型POCデバイス、ウェアラブル型POCデバイスに分けられ、それぞれ臨床ニーズ、携帯性、使いやすさに基づいて独自の長所と短所を提供しています。アプリケーションベースのセグメンテーションでは、さらに市場を診断＆スクリーニングとモニタリングに分け、これらのデバイスが心臓疾患の早期発見と継続的管理の両方で果たす二重の役割を反映しています。さらに、エンドユーザー別の分析では、外来手術センター、診断ラボ、在宅環境、病院に区分し、さまざまなケア環境でこれらの技術が多目的に利用されていることを強調しています。

このきめ細かいセグメンテーション戦略は、技術仕様と実用的なアプリケーションを融合させることで、主要動向と要件を明らかにします。これにより利害関係者は、提供される製品の技術的多様性だけでなく、これらの診断イノベーションを採用している様々な臨床環境についても理解することができます。このような洞察は、各セグメントの微妙なニーズに対応するターゲット戦略への道を開き、製品開発と市場開拓が、新興国市場の需要や患者ケアパラダイムと確実に一致するようにします。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界における心臓疾患の有病率と高齢者人口の増加
    • 患者の早期発見・診断への傾倒
    • 心臓の健康に対する政府の好意的な支援
  • 抑制要因
    • 心臓POC検査機器における製品リコールの潜在的リスク
  • 機会
    • 独自の新しいトロポニンベースの検査の導入
    • ポジティブな投資とスタートアップエコシステム
  • 課題
    • 心臓POC検査機器の正確性に関する制限と懸念事項
• 市場セグメンテーション分析
  • 製品：さまざまな心臓POC検査機器に対する規制当局の承認
  • デバイスタイプ：心臓病の管理に便利な在宅ケアを提供するウェアラブルPOCデバイスの探索
  • 応用：心臓疾患の管理において効果的な診断およびスクリーニング手順が果たす重要な役割
  • エンドユーザー：心臓の健康を改善するために病院が提供する広範かつ包括的なケア
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 心臓POC検査機器市場：製品別

• 心臓バイオマーカー検査
  • B型ナトリウム利尿ペプチド
  • クレアチンキナーゼ-MB[CK-MB]分画
  • Dダイマー検査
  • ミオグロビン検査
  • トロポニン検査
• 消耗品とアクセサリー
• デバイス
  • アナライザー
  • 画像および監視デバイス

第7章 心臓POC検査機器市場：デバイスタイプ別

• ベンチトップPOCデバイス
• ハンドヘルドPOCデバイス
• ウェアラブルPOCデバイス

第8章 心臓POC検査機器市場：用途別

• 診断とスクリーニング
• 監視

第9章 心臓POC検査機器市場：エンドユーザー別

• 外来手術センター
• 診断検査室
• ホーム設定
• 病院

第10章 南北アメリカの心臓POC検査機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の心臓POC検査機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの心臓POC検査機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ACON Laboratories, Inc.
• Alfa Scientific Designs, Inc.
• Bio-Rad Laboratories, Inc.
• Cipla Limited
• Compagnie Merieux Alliance SAS
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Getein Biotech, Inc.
• Laboratory Corporation of America Holdings
• LifeSign LLC
• Medtronic plc
• Merck KGaA
• Nano-Ditech Corp.
• Nexus Dx, Inc.
• Nova Biomedical Corporation
• Polymer Technology Systems, Inc. by Sinocare
• Precision Biosensor, Inc.
• QuidelOrtho Corporation
• Sekisui Chemical Co., Ltd.
• Siemens Healthineers AG
• Werfen, S.A.

LIST OF FIGURES

• FIGURE 1. CARDIAC POC TESTING DEVICES MARKET MULTI-CURRENCY
• FIGURE 2. CARDIAC POC TESTING DEVICES MARKET MULTI-LANGUAGE
• FIGURE 3. CARDIAC POC TESTING DEVICES MARKET RESEARCH PROCESS
• FIGURE 4. CARDIAC POC TESTING DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
• FIGURE 6. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 16. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 18. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 20. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 24. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIAC POC TESTING DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
• TABLE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 6. CARDIAC POC TESTING DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CREATINE KINASE-MB [CK-MB] FRACTION, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY D-DIMER TESTS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MYOGLOBIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CONSUMABLE & ACCESSORIES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 16. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 17. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 18. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMAGING & MONITORING DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 19. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 20. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 21. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY BENCH-TOP POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 22. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HANDHELD POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 23. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY WEARABLE POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 24. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 25. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTICS & SCREENING, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 26. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 27. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 28. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 29. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 30. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 31. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 32. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 33. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 34. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 35. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 36. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 37. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 38. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 39. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 40. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 41. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 42. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 43. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 44. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 45. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 46. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 47. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 48. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 49. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 50. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 51. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 52. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 53. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 54. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 55. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 56. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 57. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 58. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 59. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 60. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 61. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 62. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 63. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 64. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 65. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 66. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 67. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 68. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 69. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
• TABLE 70. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 71. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 72. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 73. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 74. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 75. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 76. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 77. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 78. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 79. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 80. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 81. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 82. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 83. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 84. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 85. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 86. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 87. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 88. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 89. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 90. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 91. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 92. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 93. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 94. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 95. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 96. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 97. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 98. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 99. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 100. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 101. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 102. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 103. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 104. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 105. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 106. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 107. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 108. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 109. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 110. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 111. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 112. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 113. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 114. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 115. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 116. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 117. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 118. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 119. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 120. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 121. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 122. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 123. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 124. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 125. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 126. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 127. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 128. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 129. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 130. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 131. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 132. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 133. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 134. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 135. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 136. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 137. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 138. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 139. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 140. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 141. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 142. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 143. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 144. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 145. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 146. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 147. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 148. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 156. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 157. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 158. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 159. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 160. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 161. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 162. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 163. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 164. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 165. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 166. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 167. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 168. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 169. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 170. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 171. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 172. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 173. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 174. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 175. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 176. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 177. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 178. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 179. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 180. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 181. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 182. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 183. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 184. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 185. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 186. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 187. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 188. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 189. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 190. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 191. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 192. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 193. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 194. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 195. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 196. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 197. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 198. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 199. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 200. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 201. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 202. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 203. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 204. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 205. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 206. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 207. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 208. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 209. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 210. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 211. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 212. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 213. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 214. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 215. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 216. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 217. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 218. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 219. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 220. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 221. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 222. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 223. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 224. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 225. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 226. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 227. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 228. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 229. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 230. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 231. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 232. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 233. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 234. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 235. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 236. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 237. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 238. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 239. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 240. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 241. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 242. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 243. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 244. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 245. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 246. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 247. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 248. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 249. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 250. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 251. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 252. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 253. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 254. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 255. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 256. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 257. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 258. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 259. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 260. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 261. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 262. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 263. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 264. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 265. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 266. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 267. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 268. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 269. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 270. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 271. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 272. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 273. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 274. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 275. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 276. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 277. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
• TABLE 278. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
• TABLE 279. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
• TABLE 280. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 281. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 282. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 283. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiac POC Testing Devices Market was valued at USD 1.36 billion in 2023 and is projected to grow to USD 1.52 billion in 2024, with a CAGR of 12.36%, reaching USD 3.08 billion by 2030.

The cardiac point-of-care (POC) testing market has evolved rapidly, driven by a confluence of technological advances, changing clinical needs, and demand for faster, reliable diagnostics. This dynamic field is redefining the way healthcare providers screen, diagnose, and manage cardiac conditions. Recent developments in biomarker detection and portable device engineering have resulted in highly efficient methods to rapidly assess cardiac health at the bedside or in remote settings.

Innovation and precision in diagnostic technology have become crucial for ensuring timely intervention in cardiac emergencies. As trends in patient care shift towards decentralization and patient-centric models, the relevance and applications of cardiac POC testing devices are expanding. The landscape for these devices is continuously set to experience transformative growth as the integration of advanced biomarker tests and sophisticated device engineering meets an urgent need for improved accuracy and operational flexibility.

This comprehensive overview explores the various angles of the cardiac POC testing market, shedding light on transformative market shifts, detailed segmentation insights, regional opportunities, major players, actionable strategic recommendations, and a persuasive call-to-action for decision-makers looking to capitalize on these developments.

Transformative Shifts Redefining Cardiac POC Testing

In recent years, the cardiac POC testing domain has undergone transformative shifts propelled by both technological breakthroughs and changes in clinical demand. A surge in innovation has led to the development of novel diagnostic methods that enhance early detection and ongoing monitoring of cardiac conditions. This transformation is marked by improvements in accuracy, speed, and the ability to deliver near-patient testing solutions, which ultimately contribute to better patient outcomes.

Key drivers of this shift include the integration of digital health tools and AI-assisted diagnostics, which are streamlining result interpretation and enabling more personalized treatment pathways. Advances in miniaturization and sensor technology have allowed instruments to become more portable and user-friendly, elevating their role across diverse healthcare settings. Furthermore, the focus on reducing the turnaround time for cardiac biomarker tests, alongside the integration of automated systems, is instrumental in mitigating diagnostic delays during critical periods.

These dynamic changes are shaping a market environment where rapid and accurate diagnosis is not just desirable but essential. As healthcare systems globally continue to strive for efficiency and improved patient care, the ongoing enhancements in device capabilities and diagnostic accuracy will undoubtedly set future standards and open up new avenues for market growth.

Key Insights from Market Segmentation Analysis

Understanding the intricate layers of market segmentation provides a robust framework for identifying opportunities and challenges within the cardiac POC testing market. An analysis based on product differentiates the market into segments such as Cardiac Biomarker Test, Consumables & Accessories, and Devices. The Cardiac Biomarker Test segment is itself subdivided further into specific tests including B-Type Natriuretic Peptide, Creatine Kinase-MB (CK-MB) Fraction, D-dimer Tests, Myoglobin Tests, and Troponin Tests. Meanwhile, the Devices segment is examined through the lens of Analyzers and Imaging & Monitoring Devices, highlighting the importance of both analytical performance and real-time monitoring capabilities.

Examining the market by device type exposes a division into Bench-top POC Devices, Handheld POC Devices, and Wearable POC Devices, each offering unique pros and cons based on clinical needs, portability, and ease-of-use. The application-based segmentation further divides the market into Diagnostics & Screening and Monitoring, reflecting the dual roles these devices serve in both early detection and ongoing management of cardiac conditions. Additionally, an analysis by end-user segments into Ambulatory Surgical Centers, Diagnostic Laboratories, Home Settings, and Hospitals, emphasizing the versatile utilization of these technologies across a spectrum of care environments.

This granular segmentation strategy illuminates key trends and requirements by blending technical specifications with practical applications. It helps stakeholders appreciate not only the technical diversity of the offerings but also the varied clinical settings that are adopting these diagnostic innovations. Such insights pave the way for targeted strategies that address the nuanced needs of each segment, ensuring that product development and market positioning are aligned with evolving clinical demands and patient-care paradigms.

Based on Product, market is studied across Cardiac Biomarker Test, Consumable & Accessories, and Devices. The Cardiac Biomarker Test is further studied across B-Type Natriuretic Peptide, Creatine Kinase-MB [CK-MB] Fraction, D-dimer Tests, Myoglobin Tests, and Troponin Tests. The Devices is further studied across Analyzers and Imaging & Monitoring Devices.

Based on Device Type, market is studied across Bench-top POC Devices, Handheld POC Devices, and Wearable POC Devices.

Based on Application, market is studied across Diagnostics & Screening and Monitoring.

Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Home Settings, and Hospitals.

Regional Insights Driving Market Expansion

The global market for cardiac POC testing is shaped significantly by regional dynamics that influence both technology adoption and regulatory frameworks. In the Americas, robust healthcare infrastructure coupled with a strong focus on innovation in diagnostics fuels the pace of adoption while meeting high clinical standards. The region is characterized by a mature market environment with significant investments in research and development aimed at refining cardiac biomarker tests and associated devices.

Across Europe, the Middle East, and Africa, there is a growing acknowledgment of the importance of decentralized testing solutions, underpinned by strategic government initiatives and supportive healthcare policies. Sophisticated healthcare networks and a rising emphasis on patient monitoring have contributed to the expansion of POC testing solutions in this region. In particular, improving accessibility and reducing diagnostic time barriers have been pivotal in driving market penetration.

The Asia-Pacific region presents a dynamic growth landscape, characterized by rapid urbanization, rising healthcare awareness, and significant efforts to upgrade medical infrastructure. Emerging economies in this area have witnessed accelerated investments in healthcare technology, while simultaneous policy reforms and technological adoptions are enhancing access to advanced diagnostics. The region remains a hub of technological innovation, where investments in both centralized and decentralized diagnostic tools are propelling market growth and transforming how patient care is delivered.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights on Leading Companies Shaping the Market

The cardiac POC testing arena is bolstered by contributions from several influential companies whose innovations and market strategies are redefining diagnostic excellence. Industry frontrunners such as Abbott Laboratories, ACON Laboratories, Inc., and Alfa Scientific Designs, Inc. have developed state-of-the-art diagnostic tools that combine sensitivity, specificity, and user-friendly interfaces. Other key players like Bio-Rad Laboratories, Inc., Cipla Limited, and Compagnie Merieux Alliance SAS are equally pivotal in expanding global reach and driving technology adoption.

Notable multinational corporations such as Danaher Corporation, F. Hoffmann-La Roche Ltd, and Medtronic plc continue to invest heavily in R&D to refine existing offerings and develop next-generation devices. Innovative enterprises like Getein Biotech, Inc., LifeSign LLC, and Nano-Ditech Corp. are making significant strides by introducing cutting-edge technologies that cater to emerging markets. Additional contributions from Nexus Dx, Inc., Nova Biomedical Corporation, and Polymer Technology Systems, Inc. by Sinocare, Precision Biosensor, Inc., QuidelOrtho Corporation, Sekisui Chemical Co., Ltd., Siemens Healthineers AG, and Werfen, S.A. further underscore the highly competitive and collaborative nature of this market.

Each of these companies brings a unique blend of technological excellence and strategic market positioning. Their continued drive towards innovation, combined with an increasing emphasis on reliability and performance, is set to propel the overall growth of cardiac POC testing solutions across various clinical applications and geographies. These industry leaders not only shape market trends but also establish benchmarks that other players aspire to, continually encouraging advancements in the field.

The report delves into recent significant developments in the Cardiac POC Testing Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Cipla Limited, Compagnie Merieux Alliance SAS, Danaher Corporation, F. Hoffmann-La Roche Ltd, Getein Biotech, Inc., Laboratory Corporation of America Holdings, LifeSign LLC, Medtronic plc, Merck KGaA, Nano-Ditech Corp., Nexus Dx, Inc., Nova Biomedical Corporation, Polymer Technology Systems, Inc. by Sinocare, Precision Biosensor, Inc., QuidelOrtho Corporation, Sekisui Chemical Co., Ltd., Siemens Healthineers AG, and Werfen, S.A.. Strategic Recommendations for Market Leadership

For industry leaders aiming to capitalize on the expanding cardiac POC testing landscape, a strategic approach that integrates innovation, market intelligence, and customer-centric service is essential. Based on current industry developments, it is recommended that companies invest robustly in research and development to pioneer next-generation diagnostic tools that offer enhanced accuracy and speed. Forming strategic partnerships with research institutions and technology innovators can lead to breakthrough improvements in device performance, particularly in the realm of miniaturization and integrated digital platforms.

Market leaders should also focus on building resilient supply chains and optimizing manufacturing processes to ensure rapid scalability and cost-effectiveness. Tailoring product portfolios to meet the specific requirements of segmented market groups-ranging from comprehensive biomarker tests to versatile devices suitable for both clinical and home settings-will be vital. Furthermore, leveraging data analytics to understand consumer behavior and regional disease patterns can provide a competitive edge in customizing solutions that address local healthcare challenges.

Emphasis should be placed on expanding market presence in regions with high growth potential while remaining adaptive to regulatory changes and technological advancements. Building strong customer support networks and training programs can ensure that new technologies are effectively implemented and sustained. By adopting a holistic and agile approach, companies can safeguard their market share and drive ongoing success in a competitive and evolving field.

Conclusion: Paving the Way for a Healthier Future

In conclusion, the landscape of cardiac POC testing devices is marked by rapid innovation, diverse clinical applications, and substantial growth opportunities. Technological advancements are continuously reshaping the industry, enhancing the accuracy and speed of diagnostic tests while providing critical support in both emergent and routine care settings. Detailed segmentation insights reveal the multifaceted nature of this market, from specialized biomarker tests to advanced device categories that cater to various clinical and home environments.

The regional dynamics underscore the importance of targeted strategies, given the differing regulatory frameworks, technological maturity, and healthcare infrastructures across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Furthermore, the active role of key market players is instrumental in setting industry standards and driving adoption through continuous innovation and strategic market expansion.

Ultimately, these insights not only provide a roadmap for current market trends but also highlight the pivotal role that strategic planning and technological integration play in shaping the future of cardiac care. As stakeholders work together to advance the state of diagnostic health, the collective efforts contribute significantly to improving patient outcomes and fostering a healthier, more proactive approach to cardiac management.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of cardiac disorders and rising geriatric population globally
    • 5.1.1.2. Inclination toward the early detection and diagnosis of patients
    • 5.1.1.3. Favorable government support for cardiac health
  • 5.1.2. Restraints
    • 5.1.2.1. Potential risk of product recall in Cardiac POC testing devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Implementation of unique & new troponin-based test
    • 5.1.3.2. Positive investment and startup ecosystem
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations and concerns associated with the accuracy of cardiac POC testing devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Favorable regulatory approvals for various cardiac POC testing devices
  • 5.2.2. Device Type: Exploration of wearable POC devices to provide convenient homecare for managing heart conditions
  • 5.2.3. Application: Critical role played by effective diagnostics & screening procedures in the management of cardiac diseases
  • 5.2.4. End-User: Extensive and comprehensive care provided by hospitals for improving cardiac health
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac POC Testing Devices Market, by Product

• 6.1. Introduction
• 6.2. Cardiac Biomarker Test
  • 6.2.1. B-Type Natriuretic Peptide
  • 6.2.2. Creatine Kinase-MB [CK-MB] Fraction
  • 6.2.3. D-dimer Tests
  • 6.2.4. Myoglobin Tests
  • 6.2.5. Troponin Tests
• 6.3. Consumable & Accessories
• 6.4. Devices
  • 6.4.1. Analyzers
  • 6.4.2. Imaging & Monitoring Devices

7. Cardiac POC Testing Devices Market, by Device Type

• 7.1. Introduction
• 7.2. Bench-top POC Devices
• 7.3. Handheld POC Devices
• 7.4. Wearable POC Devices

8. Cardiac POC Testing Devices Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics & Screening
• 8.3. Monitoring

9. Cardiac POC Testing Devices Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Diagnostic Laboratories
• 9.4. Home Settings
• 9.5. Hospitals

10. Americas Cardiac POC Testing Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cardiac POC Testing Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac POC Testing Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Siemens Healthineers launches NT-proBNPII assay on Atellica platform to enhance heart failure diagnosis and speed patient care
  • 13.3.2. F. Hoffmann-La Roche AG launches NT-proBNP point-of-care test on cobas h 232 to enhance early detection and management of CVD and heart failure in diabetes patients
  • 13.3.3. Analytics for Life and CorVista Health receive FDA clearance for non-invasive CorVista System with Pulmonary Hypertension
  • 13.3.4. Eko Health, Inc. and Mayo Clinic secure FDA clearance for AI-driven low ejection fraction detection
  • 13.3.5. SpinChip Diagnostics receives NOK 115 million investment from bioMerieux to commercialize next-generation cardiac POC testing devices
  • 13.3.6. Roche to acquire LumiraDx's microfluidic point-of-care technology to advance cardiovascular diagnostics
  • 13.3.7. Primary Healthtech's Mobilab device offers early detection of heart and chronic diseases with IoT integration
  • 13.3.8. EDX Medical Group Plc. acquires Hutano Diagnostics Ltd. to develop advanced smartphone-integrated POC tests
  • 13.3.9. EDX Medical Group acquires Hutano Diagnostics to revolutionize rapid healthcare tests with advanced diagnostic technology enhancing speed, accuracy, and cost-effectiveness
  • 13.3.10. Cipla launches cippoint, POC testing device to expand diagnostics portfolio with CE IVD approval, enhancing rapid clinical decision-making and market penetration
• 13.4. Strategy Analysis & Recommendation
  • 13.4.1. F. Hoffmann-La Roche Ltd.
  • 13.4.2. Siemens Healthineers AG
  • 13.4.3. Abbott Laboratories
  • 13.4.4. Danaher Corporation
  • 13.4.5. Werfen, S.A.

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACON Laboratories, Inc.
• 3. Alfa Scientific Designs, Inc.
• 4. Bio-Rad Laboratories, Inc.
• 5. Cipla Limited
• 6. Compagnie Merieux Alliance SAS
• 7. Danaher Corporation
• 8. F. Hoffmann-La Roche Ltd
• 9. Getein Biotech, Inc.
• 10. Laboratory Corporation of America Holdings
• 11. LifeSign LLC
• 12. Medtronic plc
• 13. Merck KGaA
• 14. Nano-Ditech Corp.
• 15. Nexus Dx, Inc.
• 16. Nova Biomedical Corporation
• 17. Polymer Technology Systems, Inc. by Sinocare
• 18. Precision Biosensor, Inc.
• 19. QuidelOrtho Corporation
• 20. Sekisui Chemical Co., Ltd.
• 21. Siemens Healthineers AG
• 22. Werfen, S.A.